Ozempic was found in a 2025 clinical trial to reduce measurable biological age in adults by approximately 3 to 5 years — with improvements in inflammation, cardiovascular health, and kidney function
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Ozempic was found in a 2025 clinical trial to reduce measurable biological age in adults by approximately 3 to 5 years — with improvements in inflammation, cardiovascular health, and kidney function" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Medical News Today, Conexiant, Yahoo and University of California. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 90d ago.
Quick answers
Why is "Ozempic was found in a 2025 clinical trial to reduce measurable biological age i" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Semaglutide, omega-3s and diet shift epigenetic aging clocks in human studies News-Medical · 90d ago
- UC San Diego researchers explore whether a GLP-1 drug can slow biological aging KPBS · 90d ago
- Semaglutide and aging: New study finds benefits beyond weight loss Medical News Today · 90d ago
- Semaglutide Tied to Aging Clocks in HIV Conexiant · 90d ago
- Weight loss drugs show signs of slowing biological aging, scientists discover Yahoo · 90d ago
- New study shows popular GLP-1 weight loss drug may slow biological aging University of California · 90d ago
- Ozempic was found in a 2025 clinical trial to reduce measurable biological age in adults by approximately 3 to 5 years — with improvements in inflammation, cardiovascular health, and kidney function Space Daily · 90d ago
Topics
Related trends
The weight I lost with GLP-1s came back ‘with taxes’
Recent coverage examines rapid weight regain after discontinuing GLP-1 medications like Ozempic, semaglutide, and tirzepatide.
From ‘Ozempic breath’ to hair loss: sorting the science from the hype about weight loss jabs
Medical experts and journalists are working to distinguish scientific facts from social media hype regarding side effects of GLP-1 weight loss medications.
Scientists Found a Surprising Effect of Ozempic. It Involves Your Lungs
New research indicates that GLP-1 medications like Ozempic and Wegovy may significantly reduce the frequency of asthma attacks and COPD flare-ups.
Weight regain after obesity drugs tied to higher odds of suicidal thoughts in observational study
A new observational study links weight regain following the use of obesity medications to an increased risk of suicidal thoughts.
Cravings ‘like heroin withdrawal’: what happens when weight-loss drugs don’t work?
Growing concerns emerge over the 'Ozempidemic' as users report intense cravings and safety risks associated with GLP-1 weight-loss medications.
Weight loss drugs could see men losing more than just fat
New reports suggest popular GLP‑1 weight‑loss drugs may trigger male pattern baldness, sparking medical and public‑interest scrutiny.